1、Haseeb%20AA%20%2C%20Elhusseiny%20AM%20%2C%20Siddiqui%20MZ%20%2C%20et%20al%20.%20Fungal%20%0AEndophthalmitis%3A%20A%20Comprehensive%20Review%5B%20J%5D.%C2%A0J%20Fungi%20(Basel)%2C%202021%2C%20%0A7(11)%3A%20996.%20DOI%3A10.3390%2Fjof7110996.Haseeb%20AA%20%2C%20Elhusseiny%20AM%20%2C%20Siddiqui%20MZ%20%2C%20et%20al%20.%20Fungal%20%0AEndophthalmitis%3A%20A%20Comprehensive%20Review%5B%20J%5D.%C2%A0J%20Fungi%20(Basel)%2C%202021%2C%20%0A7(11)%3A%20996.%20DOI%3A10.3390%2Fjof7110996.
2、Sheu%20SJ.Endophthalmitis%5B%20J%5D.%C2%A0Korean%20J%20Ophthalmol%2C%202017%2C%2031(4)%3A%20283-%0A289.%20DOI%3A%2010.3341%2Fkjo.2017.0036.Sheu%20SJ.Endophthalmitis%5B%20J%5D.%C2%A0Korean%20J%20Ophthalmol%2C%202017%2C%2031(4)%3A%20283-%0A289.%20DOI%3A%2010.3341%2Fkjo.2017.0036.
3、Relhan N, Forster RK, Jr Flynn HW. Endophthalmitis: then and
now[ J]. Am J Ophthalmol, 2018, 187: xx-xxvii. DOI: 10.1016/
j.ajo.2017.11.021.Relhan N, Forster RK, Jr Flynn HW. Endophthalmitis: then and
now[ J]. Am J Ophthalmol, 2018, 187: xx-xxvii. DOI: 10.1016/
j.ajo.2017.11.021.
4、Gurnani%20B%2C%20Kaur%20K.%20Endogenous%20Endophthalmitis.%20In%3A%C2%A0%20StatPearls.%20%0ATreasure%20Island%20(FL)%3A%20StatPearls%20Publishing%3B%20June%2011%2C%202023.Gurnani%20B%2C%20Kaur%20K.%20Endogenous%20Endophthalmitis.%20In%3A%C2%A0%20StatPearls.%20%0ATreasure%20Island%20(FL)%3A%20StatPearls%20Publishing%3B%20June%2011%2C%202023.
5、Danielescu C, Stanca HT, Iorga RE, et al. The diagnosis and treatment
of fungal endophthalmitis: an update[ J]. Diagnostics (Basel),
2022,12(3):679. DOI:10.3390/diagnostics12030679.Danielescu C, Stanca HT, Iorga RE, et al. The diagnosis and treatment
of fungal endophthalmitis: an update[ J]. Diagnostics (Basel),
2022,12(3):679. DOI:10.3390/diagnostics12030679.
6、Fan JC, Niederer RL, von Lany H, et al. Infectious endophthalmitis:
clinical features, management and v isual outcomes[ J]. Clin
Exp Ophthalmol, 2008, 36(7): 631-636. DOI: 10.1111/j.1442-
9071.2008.01813.x.Fan JC, Niederer RL, von Lany H, et al. Infectious endophthalmitis:
clinical features, management and v isual outcomes[ J]. Clin
Exp Ophthalmol, 2008, 36(7): 631-636. DOI: 10.1111/j.1442-
9071.2008.01813.x.
7、Wang H, Chang Y, Zhang Y, et al. Bilateral endogenous fungal
endophthalmitis: a case report[ J]. Medicine, 2023, 102(16): e33585.
DOI: 10.1097/MD.0000000000033585.Wang H, Chang Y, Zhang Y, et al. Bilateral endogenous fungal
endophthalmitis: a case report[ J]. Medicine, 2023, 102(16): e33585.
DOI: 10.1097/MD.0000000000033585.
8、罗广娥, 崔仁哲, 田莲姬, 等. 内源性眼内炎11例临床分析
[ J]. 吉林医学, 2018, 39(4): 711-712. DOI: 10.3969/j.issn.1004-
0412.2018.04.051.
Luo GE, Cui RZ, Tian LJ, et al. Clinical analysis of 11 cases with
endogenous endophthalmitis[ J]. Jilin Med J, 2018, 39(4): 711-712.
DOI: 10.3969/j.issn.1004-0412.2018.04.051.Luo GE, Cui RZ, Tian LJ, et al. Clinical analysis of 11 cases with
endogenous endophthalmitis[ J]. Jilin Med J, 2018, 39(4): 711-712.
DOI: 10.3969/j.issn.1004-0412.2018.04.051.
9、Danielescu C, Anton N, Stanca HT, et al. Endogenous endophthalmitis:
a review of case series published between 2011 and 2020[ J]. J
Ophthalmol, 2020, 2020: 8869590. DOI: 10.1155/2020/8869590.Danielescu C, Anton N, Stanca HT, et al. Endogenous endophthalmitis:
a review of case series published between 2011 and 2020[ J]. J
Ophthalmol, 2020, 2020: 8869590. DOI: 10.1155/2020/8869590.
10、Phongkhun K, Pothikamjorn T, Srisurapanont K, et al. Prevalence
of ocular candidiasis and candida endophthalmitis in patients with
candidemia: a systematic review and meta-analysis[ J]. Clin Infect Dis,
2023, 76(10): 1738-1749. DOI: 10.1093/cid/ciad064.Phongkhun K, Pothikamjorn T, Srisurapanont K, et al. Prevalence
of ocular candidiasis and candida endophthalmitis in patients with
candidemia: a systematic review and meta-analysis[ J]. Clin Infect Dis,
2023, 76(10): 1738-1749. DOI: 10.1093/cid/ciad064.
11、Chee YE, Eliott D. The role of vitrectomy in the management of fungal
endophthalmitis[ J]. Semin Ophthalmol, 2017, 32(1): 29-35. DOI:
10.1080/08820538.2016.1228396.Chee YE, Eliott D. The role of vitrectomy in the management of fungal
endophthalmitis[ J]. Semin Ophthalmol, 2017, 32(1): 29-35. DOI:
10.1080/08820538.2016.1228396.
12、陈星, 杨勋. 真菌性眼内炎的药物和手术治疗进展[ J ] .
国际眼科杂志, 2019, 19(12): 2064-2067. DOI: 10.3980/
j.issn.1672-5123.2019.12.15.
Chen X, Yang X. Advances in drugs and surgical treatment of fungal
endophthalmitis[ J]. Int Eye Sci, 2019, 19(12): 2064-2067. DOI:
10.3980/j.issn.1672-5123.2019.12.15.Chen X, Yang X. Advances in drugs and surgical treatment of fungal
endophthalmitis[ J]. Int Eye Sci, 2019, 19(12): 2064-2067. DOI:
10.3980/j.issn.1672-5123.2019.12.15.
13、Abu Talib DN, Yong MH, Nasaruddin RA, et al. Chronic endogenous
fungal endophthalmitis: diagnostic and treatment challenges: a case report[ J]. Medicine, 2021, 100(14): e25459. DOI: 10.1097/
MD.0000000000025459.Abu Talib DN, Yong MH, Nasaruddin RA, et al. Chronic endogenous
fungal endophthalmitis: diagnostic and treatment challenges: a case report[ J]. Medicine, 2021, 100(14): e25459. DOI: 10.1097/
MD.0000000000025459.
14、Ly V, Sallam A. Fungal Endophthalmitis.[M]. Treasure Island (FL):
StatPearls Publishing, 2023.Ly V, Sallam A. Fungal Endophthalmitis.[M]. Treasure Island (FL):
StatPearls Publishing, 2023.
15、Sallam A, Taylor SRJ, Khan A, et al. Factors determining visual
outcome in endogenous Candida endophthalmitis[ J]. Retina, 2012,
32(6): 1129-1134. DOI: 10.1097/IAE.0b013e31822d3a34.Sallam A, Taylor SRJ, Khan A, et al. Factors determining visual
outcome in endogenous Candida endophthalmitis[ J]. Retina, 2012,
32(6): 1129-1134. DOI: 10.1097/IAE.0b013e31822d3a34.
16、Weber C, Stasik I, Herrmann P, et al. Early Vitrectomy with Silicone Oil
Tamponade in the Management of Postoperative Endophthalmitis[ J]. J
Clin Med, 2023,12(15):5097. DOI:10.3390/jcm12155097.Weber C, Stasik I, Herrmann P, et al. Early Vitrectomy with Silicone Oil
Tamponade in the Management of Postoperative Endophthalmitis[ J]. J
Clin Med, 2023,12(15):5097. DOI:10.3390/jcm12155097.
17、段正芳,张雅杰,宋馥香,等.糖皮质类固醇激素对常见致病真菌
生长及形态的影响[ J]. 吉林医学, 1996, 17(3): 145-146.
Duan ZF, Zhang YJ, Song FX, et al. Effects of corticosteroid on the
growth and morphology of common pathogenic fungal[ J]. Jilin Med J,
1996,17(3):145-146.Duan ZF, Zhang YJ, Song FX, et al. Effects of corticosteroid on the
growth and morphology of common pathogenic fungal[ J]. Jilin Med J,
1996,17(3):145-146.
18、Sallam A , Jayakumar S, Lightman S. Intraocular deliver y of
anti-infective drugs-bacterial, v iral, fungal and parasitic[ J].
Recent Pat Antiinfect Drug Discov, 2008, 3(1): 53-63. DOI:
10.2174/157489108783413164.Sallam A , Jayakumar S, Lightman S. Intraocular deliver y of
anti-infective drugs-bacterial, v iral, fungal and parasitic[ J].
Recent Pat Antiinfect Drug Discov, 2008, 3(1): 53-63. DOI:
10.2174/157489108783413164.
19、Coats ML, Peyman GA. Intravitreal corticosteroids in the treatment
of exogenous fungal endophthalmitis[ J]. Retina, 1992, 12(1): 46-51.
DOI: 10.1097/00006982-199212010-00010.Coats ML, Peyman GA. Intravitreal corticosteroids in the treatment
of exogenous fungal endophthalmitis[ J]. Retina, 1992, 12(1): 46-51.
DOI: 10.1097/00006982-199212010-00010.
20、林晓峰, 袁敏而. 重视真菌性眼内炎诊疗规范性[ J]. 中华
实验眼科杂志, 2019, 37(5): 321-325. DOI: 10.3760/cma.
j.issn.2095-0160.2019.05.001.
Lin XF, Yuan ME. Focus on the standardization of diagnosis and
treatment of fungal endophthalmitis[ J]. Chin J Exp Ophthalmol, 2019,
37(5): 321-325. DOI: 10.3760/cma.j.issn.2095-0160.2019.05.001.Lin XF, Yuan ME. Focus on the standardization of diagnosis and
treatment of fungal endophthalmitis[ J]. Chin J Exp Ophthalmol, 2019,
37(5): 321-325. DOI: 10.3760/cma.j.issn.2095-0160.2019.05.001.
21、Ching Wen Ho D, Agarwal A, Lee CS, et al. A review of the role of
intravitreal corticosteroids as an adjuvant to antibiotics in infectious
endophthalmitis[ J]. Ocul Immunol Inflamm, 2018, 26(3): 461-468.
DOI: 10.1080/09273948.2016.1245758.Ching Wen Ho D, Agarwal A, Lee CS, et al. A review of the role of
intravitreal corticosteroids as an adjuvant to antibiotics in infectious
endophthalmitis[ J]. Ocul Immunol Inflamm, 2018, 26(3): 461-468.
DOI: 10.1080/09273948.2016.1245758.
22、Pari B, Gallucci M, Ghigo A, et al. Insight on Infections in Diabetic
Setting[ J]. Biomedicines, 2023,11(3):971. DOI:10.3390/
biomedicines11030971.Pari B, Gallucci M, Ghigo A, et al. Insight on Infections in Diabetic
Setting[ J]. Biomedicines, 2023,11(3):971. DOI:10.3390/
biomedicines11030971.
23、Gajdzis%20M%2C%20Figu%C5%82a%20K%2C%20Kami%C5%84ska%20J%2C%20et%20al.%20Endogenous%20endophthalmitis%02the%20clinical%20significance%20of%20the%20primary%20source%20of%20infection%5B%20J%5D.%20J%20Clin%20%0AMed%2C%202022%2C%2011(5)%3A%201183.%20DOI%3A%2010.3390%2Fjcm11051183.Gajdzis%20M%2C%20Figu%C5%82a%20K%2C%20Kami%C5%84ska%20J%2C%20et%20al.%20Endogenous%20endophthalmitis%02the%20clinical%20significance%20of%20the%20primary%20source%20of%20infection%5B%20J%5D.%20J%20Clin%20%0AMed%2C%202022%2C%2011(5)%3A%201183.%20DOI%3A%2010.3390%2Fjcm11051183.
24、Steeples LR, Jones NP. Staphylococcal endogenous endophthalmitis in
association with pyogenic vertebral osteomyelitis[ J]. Eye, 2016, 30(1):
152-155. DOI: 10.1038/eye.2015.200.Steeples LR, Jones NP. Staphylococcal endogenous endophthalmitis in
association with pyogenic vertebral osteomyelitis[ J]. Eye, 2016, 30(1):
152-155. DOI: 10.1038/eye.2015.200.
25、Sandhu HS, Hajrasouliha A, Kaplan HJ, et al. Diagnostic utility
of quantitative poly merase chain reaction versus culture in
endophthalmitis and uveitis[ J]. Ocul Immunol Inflamm, 2019, 27(4):
578-582. DOI: 10.1080/09273948.2018.1431291.Sandhu HS, Hajrasouliha A, Kaplan HJ, et al. Diagnostic utility
of quantitative poly merase chain reaction versus culture in
endophthalmitis and uveitis[ J]. Ocul Immunol Inflamm, 2019, 27(4):
578-582. DOI: 10.1080/09273948.2018.1431291.
26、Chen KJ, Sun MH, Chen YP, et al. Endogenous fungal endophthalmitis:
causative organisms, treatments, and visual outcomes[ J]. JoF, 2022,
8(6): 641. DOI: 10.3390/jof8060641.Chen KJ, Sun MH, Chen YP, et al. Endogenous fungal endophthalmitis:
causative organisms, treatments, and visual outcomes[ J]. JoF, 2022,
8(6): 641. DOI: 10.3390/jof8060641.